Michal Kurlapski

Gdansk, PM 80214, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

Journal: Biomedicines
Published: May 25, 2026

PIM kinase inhibition attenuates pro-tumoral and immunosuppressive functions of macrophages in classic Hodgkin lymphoma.

PIM kinase inhibition attenuates pro-tumoral and immunosuppressive functions of macrophages in classic Hodgkin lymphoma.

Journal: Cell death & disease
Published: August 05, 2025

Metabolic Interactions in the Tumor Microenvironment of Classical Hodgkin Lymphoma: Implications for Targeted Therapy.

Metabolic Interactions in the Tumor Microenvironment of Classical Hodgkin Lymphoma: Implications for Targeted Therapy.

Journal: International journal of molecular sciences
Published: June 20, 2025

A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.

A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.

Journal: Blood
Published: October 23, 2024

Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis.

Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis.

Journal: Cancers
Published: March 17, 2024

Revisiting the predictive role of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography on treatment outcome in early-stage favorable Hodgkin lymphoma.

Revisiting the predictive role of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography on treatment outcome in early-stage favorable Hodgkin lymphoma.

Journal: Hematological oncology
Published: January 30, 2023

SARS‑CoV‑2-induced remission of advanced classical Hodgkin lymphoma.

SARS‑CoV‑2-induced remission of advanced classical Hodgkin lymphoma.

Journal: Polish archives of internal medicine
Published: May 27, 2022

Profound neutropenia related to consolidation durvalumab treatment following concurrent radiochemotherapy in a patient with stage III non-small‑cell lung cancer.

Profound neutropenia related to consolidation durvalumab treatment following concurrent radiochemotherapy in a patient with stage III non-small‑cell lung cancer.

Journal: Polish archives of internal medicine
Published: December 01, 2021

FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma.

FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma.

Journal: Cancers
Published: June 22, 2021

TMAS - Maritime Telemedical Assistance Service at the University Centre of Maritime and Tropical Medicine in Gdynia. The first year activity report.

TMAS - Maritime Telemedical Assistance Service at the University Centre of Maritime and Tropical Medicine in Gdynia. The first year activity report.

Journal: International maritime health
Published: September 26, 2014
Showing 1-10 of 10

Last Updated: 09/26/2026